Topco Scientific Co.,Ltd. Logo

Topco Scientific Co.,Ltd.

5434.TW

(4.0)
Stock Price

306,50 TWD

9.16% ROA

21.75% ROE

16.81x PER

Market Cap.

54.175.268.000,00 TWD

31.96% DER

3.48% Yield

6.39% NPM

Topco Scientific Co.,Ltd. Stock Analysis

Topco Scientific Co.,Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Topco Scientific Co.,Ltd. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (21.38%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 DER

The stock has a low debt to equity ratio (40%), which means it has a small amount of debt compared to the ownership it holds

3 Net Profit Growth

This company has consistently achieved strong net profit growth over the past five years, demonstrating a solid financial performance and making it an appealing investment option.

4 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

5 Dividend Growth

The company's dividend growth has consistently increased every year in the last five years, indicating a strong track record of positive returns for investors.

6 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

7 ROA

The stock's ROA (8.8%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

8 PBV

The stock's PBV ratio (2.39x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

9 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

10 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (3.916) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

11 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

Topco Scientific Co.,Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Topco Scientific Co.,Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Topco Scientific Co.,Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Topco Scientific Co.,Ltd. Revenue
Year Revenue Growth
2006 8.721.319.000
2007 14.967.055.000 41.73%
2008 14.464.387.000 -3.48%
2009 10.197.132.000 -41.85%
2010 14.664.596.000 30.46%
2011 15.927.661.000 7.93%
2012 16.285.679.000 2.2%
2013 15.554.749.000 -4.7%
2014 18.092.281.000 14.03%
2015 19.078.870.000 5.17%
2016 22.629.436.000 15.69%
2017 23.781.012.000 4.84%
2018 28.861.199.000 17.6%
2019 31.700.516.000 8.96%
2020 36.167.994.000 12.35%
2021 42.668.966.000 15.24%
2022 52.978.215.000 19.46%
2023 49.969.352.000 -6.02%
2023 49.261.433.000 -1.44%
2024 55.164.384.000 10.7%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Topco Scientific Co.,Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 5.517.000 100%
2018 22.353.000 75.32%
2019 77.361.000 71.11%
2020 100.230.000 22.82%
2021 101.172.000 0.93%
2022 156.411.000 35.32%
2023 79.684.000 -96.29%
2023 117.479.000 32.17%
2024 67.004.000 -75.33%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Topco Scientific Co.,Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 333.977.000
2007 387.582.000 13.83%
2008 375.354.000 -3.26%
2009 293.071.000 -28.08%
2010 414.439.000 29.28%
2011 503.998.000 17.77%
2012 433.831.000 -16.17%
2013 489.264.000 11.33%
2014 571.911.000 14.45%
2015 640.610.000 10.72%
2016 770.275.000 16.83%
2017 822.186.000 6.31%
2018 879.256.000 6.49%
2019 885.021.000 0.65%
2020 1.007.774.000 12.18%
2021 1.239.157.000 18.67%
2022 1.521.832.000 18.57%
2023 1.466.700.000 -3.76%
2023 1.430.119.000 -2.56%
2024 1.736.596.000 17.65%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Topco Scientific Co.,Ltd. EBITDA
Year EBITDA Growth
2006 670.873.000
2007 907.590.000 26.08%
2008 269.320.000 -236.99%
2009 422.654.000 36.28%
2010 812.701.000 47.99%
2011 1.189.880.000 31.7%
2012 1.024.538.000 -16.14%
2013 1.052.701.000 2.68%
2014 1.143.483.000 7.94%
2015 1.344.633.000 14.96%
2016 1.649.484.000 18.48%
2017 1.519.181.000 -8.58%
2018 2.009.245.000 24.39%
2019 2.529.489.000 20.57%
2020 2.792.132.000 9.41%
2021 3.427.505.000 18.54%
2022 4.529.075.000 24.32%
2023 4.851.924.000 6.65%
2023 3.700.571.000 -31.11%
2024 4.463.220.000 17.09%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Topco Scientific Co.,Ltd. Gross Profit
Year Gross Profit Growth
2006 1.378.883.000
2007 1.617.251.000 14.74%
2008 1.524.944.000 -6.05%
2009 986.356.000 -54.6%
2010 1.565.118.000 36.98%
2011 1.954.692.000 19.93%
2012 1.927.497.000 -1.41%
2013 1.963.065.000 1.81%
2014 2.167.181.000 9.42%
2015 2.436.355.000 11.05%
2016 2.919.679.000 16.55%
2017 2.939.972.000 0.69%
2018 3.402.970.000 13.61%
2019 3.918.813.000 13.16%
2020 4.304.750.000 8.97%
2021 5.212.204.000 17.41%
2022 6.525.364.000 20.12%
2023 6.972.476.000 6.41%
2023 6.078.324.000 -14.71%
2024 7.438.588.000 18.29%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Topco Scientific Co.,Ltd. Net Profit
Year Net Profit Growth
2006 438.831.000
2007 614.534.000 28.59%
2008 307.778.000 -99.67%
2009 344.067.000 10.55%
2010 659.994.000 47.87%
2011 952.453.000 30.71%
2012 804.405.000 -18.4%
2013 797.569.000 -0.86%
2014 859.697.000 7.23%
2015 958.221.000 10.28%
2016 1.203.347.000 20.37%
2017 997.625.000 -20.62%
2018 1.404.675.000 28.98%
2019 1.722.308.000 18.44%
2020 2.068.350.000 16.73%
2021 2.294.458.000 9.85%
2022 3.018.478.000 23.99%
2023 3.167.652.000 4.71%
2023 2.835.024.000 -11.73%
2024 4.082.448.000 30.56%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Topco Scientific Co.,Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 3
2007 3 33.33%
2008 2 -200%
2009 2 50%
2010 4 50%
2011 6 20%
2012 5 -25%
2013 5 0%
2014 5 20%
2015 6 0%
2016 7 28.57%
2017 6 -40%
2018 8 28.57%
2019 9 22.22%
2020 11 18.18%
2021 13 8.33%
2022 16 25%
2023 17 5.88%
2023 15 -13.33%
2024 22 28.57%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Topco Scientific Co.,Ltd. Free Cashflow
Year Free Cashflow Growth
2006 22.625.000
2007 43.839.000 48.39%
2008 229.991.000 80.94%
2009 1.229.143.000 81.29%
2010 696.184.000 -76.55%
2011 439.406.000 -58.44%
2012 680.584.000 35.44%
2013 302.615.000 -124.9%
2014 393.314.000 23.06%
2015 83.644.000 -370.22%
2016 1.060.769.000 92.11%
2017 316.082.000 -235.6%
2018 802.271.000 60.6%
2019 1.441.769.000 44.36%
2020 1.724.337.000 16.39%
2021 2.180.848.000 20.93%
2022 2.791.703.000 21.88%
2023 205.913.000 -1255.77%
2023 81.372.000 -153.05%
2024 892.297.000 90.88%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Topco Scientific Co.,Ltd. Operating Cashflow
Year Operating Cashflow Growth
2006 150.265.000
2007 65.532.000 -129.3%
2008 238.347.000 72.51%
2009 1.233.053.000 80.67%
2010 715.284.000 -72.39%
2011 604.309.000 -18.36%
2012 1.203.021.000 49.77%
2013 693.934.000 -73.36%
2014 1.047.024.000 33.72%
2015 710.058.000 -47.46%
2016 1.733.687.000 59.04%
2017 823.669.000 -110.48%
2018 1.093.754.000 24.69%
2019 1.757.968.000 37.78%
2020 2.006.645.000 12.39%
2021 2.596.866.000 22.73%
2022 3.183.551.000 18.43%
2023 211.709.000 -1403.74%
2023 1.907.687.000 88.9%
2024 992.074.000 -92.29%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Topco Scientific Co.,Ltd. Capital Expenditure
Year Capital Expenditure Growth
2006 127.640.000
2007 21.693.000 -488.39%
2008 8.356.000 -159.61%
2009 3.910.000 -113.71%
2010 19.100.000 79.53%
2011 164.903.000 88.42%
2012 522.437.000 68.44%
2013 391.319.000 -33.51%
2014 653.710.000 40.14%
2015 626.414.000 -4.36%
2016 672.918.000 6.91%
2017 507.587.000 -32.57%
2018 291.483.000 -74.14%
2019 316.199.000 7.82%
2020 282.308.000 -12%
2021 416.018.000 32.14%
2022 391.848.000 -6.17%
2023 5.796.000 -6660.66%
2023 1.826.315.000 99.68%
2024 99.777.000 -1730.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Topco Scientific Co.,Ltd. Equity
Year Equity Growth
2006 3.305.761.000
2007 3.628.540.000 8.9%
2008 3.528.428.000 -2.84%
2009 3.711.963.000 4.94%
2010 4.152.351.000 10.61%
2011 4.718.671.000 12%
2012 4.846.512.000 2.64%
2013 5.297.372.000 8.51%
2014 5.601.226.000 5.42%
2015 5.941.581.000 5.73%
2016 6.404.877.000 7.23%
2017 7.580.567.000 15.51%
2018 8.586.568.000 11.72%
2019 9.531.114.000 9.91%
2020 10.588.314.000 9.98%
2021 11.878.648.000 10.86%
2022 13.270.999.000 10.49%
2023 15.344.311.000 13.51%
2023 14.645.298.000 -4.77%
2024 15.638.018.000 6.35%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Topco Scientific Co.,Ltd. Assets
Year Assets Growth
2006 6.176.411.000
2007 7.819.455.000 21.01%
2008 6.744.089.000 -15.95%
2009 6.758.600.000 0.21%
2010 7.885.536.000 14.29%
2011 8.255.664.000 4.48%
2012 8.629.326.000 4.33%
2013 9.158.980.000 5.78%
2014 10.368.319.000 11.66%
2015 11.228.275.000 7.66%
2016 13.272.382.000 15.4%
2017 14.868.982.000 10.74%
2018 17.237.405.000 13.74%
2019 19.639.504.000 12.23%
2020 21.451.715.000 8.45%
2021 25.174.443.000 14.79%
2022 29.880.275.000 15.75%
2023 31.635.539.000 5.55%
2023 31.875.509.000 0.75%
2024 35.569.679.000 10.39%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Topco Scientific Co.,Ltd. Liabilities
Year Liabilities Growth
2006 2.870.650.000
2007 4.190.915.000 31.5%
2008 3.215.661.000 -30.33%
2009 3.046.637.000 -5.55%
2010 3.733.185.000 18.39%
2011 3.536.993.000 -5.55%
2012 3.782.814.000 6.5%
2013 3.861.608.000 2.04%
2014 4.767.093.000 18.99%
2015 5.286.694.000 9.83%
2016 6.867.505.000 23.02%
2017 7.288.415.000 5.78%
2018 8.650.837.000 15.75%
2019 10.108.390.000 14.42%
2020 10.863.401.000 6.95%
2021 13.295.795.000 18.29%
2022 16.609.276.000 19.95%
2023 16.291.228.000 -1.95%
2023 17.230.211.000 5.45%
2024 19.931.661.000 13.55%

Topco Scientific Co.,Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
267.28
Net Income per Share
17.07
Price to Earning Ratio
16.81x
Price To Sales Ratio
1.07x
POCF Ratio
13.01
PFCF Ratio
-193.36
Price to Book Ratio
3.51
EV to Sales
1.08
EV Over EBITDA
12.79
EV to Operating CashFlow
13.12
EV to FreeCashFlow
-195.01
Earnings Yield
0.06
FreeCashFlow Yield
-0.01
Market Cap
54,18 Bil.
Enterprise Value
54,64 Bil.
Graham Number
177.24
Graham NetNet
-27.56

Income Statement Metrics

Net Income per Share
17.07
Income Quality
1.19
ROE
0.22
Return On Assets
0.09
Return On Capital Employed
0.18
Net Income per EBT
0.82
EBT Per Ebit
1.03
Ebit per Revenue
0.08
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.13
Operating Profit Margin
0.08
Pretax Profit Margin
0.08
Net Profit Margin
0.06

Dividends

Dividend Yield
0.03
Dividend Yield %
3.48
Payout Ratio
0.56
Dividend Per Share
10

Operating Metrics

Operating Cashflow per Share
22.06
Free CashFlow per Share
-1.48
Capex to Operating CashFlow
1.07
Capex to Revenue
0.09
Capex to Depreciation
9.21
Return on Invested Capital
0.14
Return on Tangible Assets
0.09
Days Sales Outstanding
69.84
Days Payables Outstanding
66.22
Days of Inventory on Hand
37.43
Receivables Turnover
5.23
Payables Turnover
5.51
Inventory Turnover
9.75
Capex per Share
23.55

Balance Sheet

Cash per Share
27,81
Book Value per Share
82,86
Tangible Book Value per Share
80.74
Shareholders Equity per Share
81.8
Interest Debt per Share
26.77
Debt to Equity
0.32
Debt to Assets
0.14
Net Debt to EBITDA
0.11
Current Ratio
1.37
Tangible Asset Value
15,24 Bil.
Net Current Asset Value
0,25 Bil.
Invested Capital
15545960000
Working Capital
5,47 Bil.
Intangibles to Total Assets
0.01
Average Receivables
9,09 Bil.
Average Payables
7,53 Bil.
Average Inventory
4296155000
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Topco Scientific Co.,Ltd. Dividends
Year Dividends Growth
2001 1
2002 1 0%
2003 3 50%
2004 3 0%
2005 2 0%
2006 2 0%
2007 2 0%
2008 3 0%
2009 1 -100%
2010 1 0%
2011 2 100%
2012 4 33.33%
2013 3 0%
2014 3 0%
2015 3 0%
2016 4 0%
2017 5 25%
2018 4 0%
2019 5 20%
2020 7 16.67%
2021 8 25%
2022 9 0%
2023 10 11.11%
2024 10 0%

Topco Scientific Co.,Ltd. Profile

About Topco Scientific Co.,Ltd.

Topco Scientific Co., Ltd. provides precision materials, processing equipment, and components for semiconductor and opto-electronic industries in Taiwan, China, and internationally. It also offers semiconductor related products, such as wafer and wafer processing materials; wafer carriers; thin films; photolithography materials; etching and furnace products, including quartz glass products, chemical, and special gases; CMP slurry products; package and testing related materials and equipment; and semiconductor equipment. In addition, the company offers LCD related equipment and materials; LED related photoelectric related products; solar materials comprising conductive paste for solar cells, quartz crucibles, SiC powder, coolants, diamond wires, chemicals, and special gases; and electronic materials. Further, it undertakes water treatment, clean room and electromechanical, and public construction projects; and solar power plant projects, as well as provides IC foundry services. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

CEO
Mr. Simon Tseng
Employee
1.604
Address
No. 483, Tiding Boulevard
Taipei, 11493

Topco Scientific Co.,Ltd. Executives & BODs

Topco Scientific Co.,Ltd. Executives & BODs
# Name Age
1 Qing Fu Yang
Chief Operating Officer
70
2 Mr. De Yi Chen
Chief Executive Officer
70
3 Ms. Joyce Lu
Chief Executive Officer, Chief Financial Officer & Representative Director
70
4 Mr. Henry Ho
Chief Operating Officer
70
5 Fa Xiang Tan
Chief Operating Officer
70
6 Mr. Daniel Wu
Chief Executive Officer
70
7 Mr. Charles Lee
President, Chief Executive Officer & Director
70
8 Mr. Yung-Jan Chang
Founder
70
9 Mr. Simon Tseng
President, Chief Executive Officer & Director
70
10 Mr. Eugene Lee
Chief Executive Officer
70

Topco Scientific Co.,Ltd. Competitors